Proteome Sciences (LON:PRM) Announces Quarterly Earnings Results

Proteome Sciences (LON:PRM) posted its quarterly earnings results on Wednesday. The company reported GBX (0.41) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Stock Up 2.8%

PRM stock traded up GBX 0.04 during trading hours on Thursday, hitting GBX 1.49. The company’s stock had a trading volume of 5,201,953 shares, compared to its average volume of 402,144. Proteome Sciences has a 12 month low of GBX 1.11 and a 12 month high of GBX 4.40. The company has a market capitalization of £5.23 million, a PE ratio of -1.43 and a beta of 0.16. The stock has a 50 day moving average price of GBX 1.71 and a two-hundred day moving average price of GBX 1.64. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.